Peter W Marks
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 2%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 14
- Acute Myeloid Leukemia Research 6
- Genetics 11
- Hemoglobinopathies and Related Disorders 9
- Co-authors
- Robert M. Califf (4 shared papers)David J. Kwiatkowski (6 shared papers)Janet Woodcock (3 shared papers)Frederick R. Maxfield (4 shared papers)Nicole C. Verdun (4 shared papers)Steven A. Anderson (6 shared papers)Gerry W. Gray (1 shared paper)Jeffrey E. Shuren (1 shared paper)
- Journals
- New England Journal of Medicine (14 papers)Blood (11 papers)Transfusion (6 papers)JAMA (5 papers)American Journal of Hematology (3 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Peter W Marks
113 papers receiving 6.8k citations
Peter W Marks's Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 963
- Genetics 357
- Internal Medicine 119
- Hematology 333
- Oncology 434
Countries citing papers authored by Peter W Marks
This map shows the geographic impact of Peter W Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W Marks more than expected).
Fields of papers citing papers by Peter W Marks
This network shows the impact of papers produced by Peter W Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W Marks. The network helps show where Peter W Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter W Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-World Evidence — What Is It and What Can It Tell Us? Hit paper breakdown → | 2016 | 1592 |
| 2 | Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 Hit paper breakdown → | 2021 | 410 |
| 3 | 2020 | 365 | |
| 4 | 1999 | 329 | |
| 5 | 2020 | 327 | |
| 6 | 2003 | 259 | |
| 7 | 2021 | 235 | |
| 8 | 2006 | 232 | |
| 9 | 2016 | 229 | |
| 10 | Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy Hit paper breakdown → | 2024 | 215 |
| 11 | 2000 | 192 | |
| 12 | 2004 | 136 | |
| 13 | 2018 | 136 | |
| 14 | 2002 | 123 | |
| 15 | 2014 | 115 | |
| 16 | 2016 | 113 | |
| 17 | 1991 | 98 | |
| 18 | 1991 | 98 | |
| 19 | 1990 | 86 | |
| 20 | 2002 | 85 |
About Peter W Marks
Peter W Marks is a scholar working on Hematology, Genetics, Infectious Diseases, Internal Medicine and Management of Technology and Innovation, having authored 116 papers that have together received 7.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), Hemoglobinopathies and Related Disorders (9 papers), Acute Myeloid Leukemia Research (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Biomedical Ethics and Regulation (6 papers), COVID-19 Clinical Research Studies (5 papers), Blood donation and transfusion practices (4 papers) and Mosquito-borne diseases and control (3 papers). The work is most often cited by research in Infectious Diseases (963 citations), Genetics (357 citations), Internal Medicine (119 citations), Hematology (333 citations) and Oncology (434 citations). Peter W Marks has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Robert M. Califf, David J. Kwiatkowski, Janet Woodcock, Frederick R. Maxfield, Nicole C. Verdun, Steven A. Anderson, Gerry W. Gray, Jeffrey E. Shuren, Danica Marinac‐Dabic and Thomas P. Gross. Their work appears in journals such as New England Journal of Medicine, Blood, Transfusion, JAMA and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.